Literature DB >> 8961171

Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa.

S Lang1, P Langguth, R Oschmann, B Traving, H P Merkle.   

Abstract

Thymocartin (TP4, Arg-Lys-Asp-Val) is the 32-35 fragment of the naturally occurring thymic factor (thymopoietin). Here studies on the nasal transport and metabolism of TP4 were performed. Freshly excised bovine nasal mucosa was taken as a model membrane. For permeation studies typical donor-receiver experiments (side-by-side) and finite-dose experiments with small volumes of highly concentrated solutions were carried out. The metabolic pathway of TP4 in nasal mucosa was found to occur according to a typical aminopeptidase cleavage pattern, stepwise forming Lys-Asp-Val and Asp-Val. TP4 metabolism experiments under reflection kinetics showed a saturation profile above 0.5 mumol mL-1. A non-linear kinetic model consisting of three steps in sequence was sufficient to describe the kinetics: for the first step saturable Michaelis-Meat kinetics, and for the second and the third step first-order kinetics were assured. The model was capable of simultaneously fitting the data for the full range of initial concentrations from 0.1 up to 1.0 mumol mL-1. Saturation kinetics was also found to be the prominent feature of the permeation experiments performed. In the lower concentration range (< 0.4 mumol mL-1), transport of TP4 across nasal mucosa was controlled by metabolism, in the higher concentration range (> 0.85 mumol mL-1) diffusion control became more important. We conclude that enhancement of absorption can be achieved when nasal aminopeptidases are saturated, e.g. at high TP4 concentrations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8961171     DOI: 10.1111/j.2042-7158.1996.tb03919.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  6 in total

1.  Nasal epithelial permeation of thymotrinan (TP3) versus thymocartin (TP4): competitive metabolism and self-enhancement.

Authors:  M C Schmidt; W Rubas; H P Merkle
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58).

Authors:  Rachel Tréhin; Hanne M Nielsen; Heinz-Georg Jahnke; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle
Journal:  Biochem J       Date:  2004-09-15       Impact factor: 3.857

3.  Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.

Authors:  Rachel Tréhin; Ulrike Krauss; Annette G Beck-Sickinger; Hans P Merkle; Hanne M Nielsen
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

4.  Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan.

Authors:  Rita J Majithiya; Pradip K Ghosh; Manish L Umrethia; Rayasa S R Murthy
Journal:  AAPS PharmSciTech       Date:  2006-08-04       Impact factor: 3.246

5.  Carbopol-based gels for nasal delivery of progesterone.

Authors:  Grace Rathnam; N Narayanan; R Ilavarasan
Journal:  AAPS PharmSciTech       Date:  2008-10-11       Impact factor: 3.246

6.  Synthesis, Characterization and In Vitro Evaluation of a Novel Glycol Chitosan-EDTA Conjugate to Inhibit Aminopeptidase-Mediated Degradation of Thymopoietin Oligopeptides.

Authors:  Jiao Feng; Yan Chen; Feng Li; Lili Cui; Nianqiu Shi; Wei Kong; Yong Zhang
Journal:  Molecules       Date:  2017-07-26       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.